Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients
- PMID: 11139531
- DOI: 10.1093/humrep/16.1.24
Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients
Abstract
Ovarian hyperstimulation syndrome (OHSS) can be a severe and potentially life-threatening complication of ovarian stimulation for IVF. Coasting or withholding gonadotrophin stimulation relies on frequent estimation of serum oestradiol to identify patients at risk. A modified coasting protocol was developed in which identification of patients at risk of severe OHSS was based on ultrasound monitoring. Serum oestradiol concentrations were measured only in patients with >20 follicles on ultrasound (high risk). If serum oestradiol concentrations were <3000 pmol/l, the gonadotrophin dose was maintained; if concentrations were >/=3000 pmol/l but <13200 pmol/l and >/=25% of the follicles had a diameter of >/=13 mm, the gonadotrophin dose was halved; and if serum oestradiol concentrations were >/=13 200 pmol/l and >/=25% of the follicles had a diameter of >/=15 mm, patients were coasted. In the latter group, human chorionic gonadotrophin (HCG) 10000 IU was administered when at least three follicles had a diameter of >/=18 mm and serum oestradiol concentrations were <10000 pmol/l. Over a 10 month period, serum oestradiol concentrations were measured in 123 out of 580 cycles (24%) and in 50 cycles, gonadotrophins were withheld. Overall, moderate OHSS occurred in three patients (0.7%) and severe OHSS in one patient (0.2%). The pregnancy rates in the cycles where the gonadotrophin dose was reduced or withheld were 39.6 and 40% per cycle respectively; corresponding implantation rates were 30.7 and 25.6%. It is concluded that the modified coasting strategy is associated with a low risk of moderate and severe OHSS to a minimum without compromising pregnancy rates. Identification of patients at risk by ultrasound reduces the number of serum oestradiol measurements and thus inconvenience to patients as well as costs and workload.
Similar articles
-
The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization.Hum Fertil (Camb). 2006 Sep;9(3):175-80. doi: 10.1080/14647270600787575. Hum Fertil (Camb). 2006. PMID: 17008270
-
Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?Hum Reprod. 1998 May;13(5):1157-8. doi: 10.1093/humrep/13.5.1157. Hum Reprod. 1998. PMID: 9647538
-
High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by 'prolonged coasting' of very hyperstimulated patients: a multicentre study.Hum Reprod. 1999 Feb;14(2):294-7. doi: 10.1093/humrep/14.2.294. Hum Reprod. 1999. PMID: 10099966 Clinical Trial.
-
The prevention of ovarian hyperstimulation syndrome.J Obstet Gynaecol Can. 2014 Nov;36(11):1024-1033. doi: 10.1016/S1701-2163(15)30417-5. J Obstet Gynaecol Can. 2014. PMID: 25574681 Review. English, French.
-
Symposium: Update on prediction and management of OHSS. Prevention of OHSS.Reprod Biomed Online. 2009 Jul;19(1):33-42. doi: 10.1016/s1472-6483(10)60043-0. Reprod Biomed Online. 2009. PMID: 19573288 Review.
Cited by
-
Ovarian Hyperstimulation Syndrome (OHSS): A Narrative Review and Legal Implications.J Pers Med. 2024 Aug 28;14(9):915. doi: 10.3390/jpm14090915. J Pers Med. 2024. PMID: 39338169 Free PMC article. Review.
-
Effectiveness, Flexibility and Safety of Switching IVF to IVM as a Rescue Strategy in Unexpected Poor Ovarian Response for PCOS Infertility Patients.J Clin Med. 2023 Mar 2;12(5):1978. doi: 10.3390/jcm12051978. J Clin Med. 2023. PMID: 36902766 Free PMC article.
-
VEGF antagonist for the prevention of ovarian hyperstimulation syndrome: Current status.Med J Armed Forces India. 2014 Jan;70(1):58-63. doi: 10.1016/j.mjafi.2012.03.005. Epub 2012 Sep 11. Med J Armed Forces India. 2014. PMID: 24623949 Free PMC article. Review.
-
Whether Letrozole could reduce the incidence of early ovary hyperstimulation syndrome after assisted reproductive technology? A systematic review and meta-analysis.Reprod Health. 2020 Nov 20;17(1):181. doi: 10.1186/s12978-020-01042-2. Reprod Health. 2020. PMID: 33218353 Free PMC article.
-
Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation.Cochrane Database Syst Rev. 2016 Nov 16;11(11):CD008720. doi: 10.1002/14651858.CD008720.pub2. Cochrane Database Syst Rev. 2016. PMID: 27852101 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources